Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,266 | 11,609 | 5,514 | 18,974 | 19,166 |
| Marketable Securities | 58,988 | 52,267 | 23,363 | 14,244 | N/A |
| Receivables | 323 | 321 | 620 | 41 | 1,868 |
| Other current assets | 0 | 0 | 0 | 36 | 0 |
| TOTAL | $82,417 | $64,807 | $30,080 | $33,528 | $21,418 |
| Non-Current Assets | |||||
| PPE Net | 1,887 | 1,643 | 1,958 | 2,076 | 867 |
| Investments And Advances | 2,502 | 2,531 | 0 | 0 | 0 |
| Intangibles | 2,117 | 2,117 | 2,117 | 2,117 | 2,117 |
| Other Non-Current Assets | 512 | 441 | 290 | 504 | 569 |
| TOTAL | $7,018 | $6,732 | $4,365 | $4,697 | $3,553 |
| Total Assets | $89,435 | $71,539 | $34,445 | $38,225 | $24,971 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,133 | 459 | 624 | 600 | 401 |
| Accrued Expenses | 1,894 | 2,333 | 1,219 | 1,457 | 3,257 |
| Other current liabilities | 44 | 329 | N/A | N/A | N/A |
| TOTAL | $3,071 | $4,870 | $1,861 | $2,075 | $3,676 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 3,059 | 199 | 199 | 199 |
| Deferred Revenues | N/A | N/A | 18 | 18 | 18 |
| Other Non-Current Liabilities | 3,508 | 29,560 | 13,013 | 10,089 | 30 |
| TOTAL | $4,041 | $33,236 | $13,727 | $10,732 | $578 |
| Total Liabilities | $7,112 | $38,106 | $15,588 | $12,807 | $4,254 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,538 | 7,270 | 5,016 | 4,293 | 3,249 |
| Common Shares | 353,853 | 353,851 | 353,850 | 345,836 | 325,043 |
| Retained earnings | -393,326 | -389,911 | -347,255 | -331,637 | -314,418 |
| Other shareholders' equity | -5,036 | -5,044 | -5,066 | -5,066 | -5,002 |
| TOTAL | $82,323 | $33,433 | $18,857 | $25,418 | $20,717 |
| Total Liabilities And Equity | $89,435 | $71,539 | $34,445 | $38,225 | $24,971 |